Description
Cdc7-IN-7 (compound I-E) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-E. Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle.
Product information
CAS Number: 1402059-17-9
Molecular Weight: 410.42
Formula: C21H22N4O5
Chemical Name: cyclopropylmethyl 4-hydroxy-2-[(morpholin-4-yl)amino]-5-{[(3Z)-3H-pyrrolo[2,3-b]pyridin-3-ylidene]methyl}furan-3-carboxylate
Smiles: OC1C(C(=O)OCC2CC2)=C(NN2CCOCC2)OC=1/C=C1\C=NC2=NC=CC=C\12
InChiKey: SVOSLACSFSSYFI-GXDHUFHOSA-N
InChi: InChI=1S/C21H22N4O5/c26-18-16(10-14-11-23-19-15(14)2-1-5-22-19)30-20(24-25-6-8-28-9-7-25)17(18)21(27)29-12-13-3-4-13/h1-2,5,10-11,13,24,26H,3-4,6-9,12H2/b14-10+
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.